tert-Butyl 3-bromo-6-chloropicolinate

Catalog No. :
ACABFH590
CAS No. :
1235036-15-3
Molecular Formula :
C10H11BrClNO2
Molecular Weight :
292.56

IUPAC Name:tert-butyl 3-bromo-6-chloropicolinate

tert-Butyl 3-bromo-6-chloropicolinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$60.00Login to see priceIn stockIn stock
25g97%$233.00Login to see priceIn stockIn stock
100g97%$929.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-bromo-6-chloropicolinate
IUPAC Nametert-butyl 3-bromo-6-chloropicolinate
MDL No.MFCD19443279
Molecular FormulaC10H11BrClNO2
Molecular Weight292.56
SMILESO=C(OC(C)(C)C)C1=NC(Cl)=CC=C1Br
InChI KeyJKGXLKXQUDHRLL-UHFFFAOYSA-N
SynonymSCHEMBL3361445 | tert-butyl 3-bromo-6-chloropyridine-2-carboxylate | MFCD19443279 | tert-Butyl3-bromo-6-chloropicolinate | tert-Butyl 3-bromo-6-chloropicolinate | 2-Pyridinecarboxylic acid, 3-bromo-6-chloro-, 1,1-dimethylethyl ester | DTXSID20732098
CAS No.1235036-15-3
PubChem CID59447676

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330

Synthetic Route by SureRoute

1. ACABFH590 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIEFQ450 route compound structure diagram
    ACIEFQ450929000-66-8 In Stock
  4. Then
  5. ACABFH590 route product structure diagram
    ACABFH5901235036-15-3 In Stock
Inquiry

2. ACABFH590 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. ACIEFQ450 route compound structure diagram
    ACIEFQ450929000-66-8 In Stock
  4. Then
  5. ACABFH590 route product structure diagram
    ACABFH5901235036-15-3 In Stock
Inquiry

Comments (0)